Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

Conditions: Type 2 Diabetes Interventions: Drug: Empagliflozin 25 MG; Drug: Sitagliptin 100mg Sponsors: Medanta, The Medicity, India; Diabetes& Endocrinology Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials